The infection of Streptococcus pyogenes T253 with the temperate bacteriophage T12 results in the conversion of the nontoxigenic strain to type A streptococcal exotoxin (erythrogenic toxin) production. Although previous research has established that integration of the bacteriophage genome into the host chromosome is not essential for exotoxin production, the location of the gene on the bacteriophage or bacterial chromosome had not been determined. In the present investigation, recombinant DNA techniques were used to determine whether the gene specifying type A streptococcal exotoxin (speA) production is located on the bacteriophage chromosome. Bacteriophage T12 was obtained from S. pyogenes T253(T12) by induction with mitomycin C, and after isolation of bacteriophage DNA by phenol-chloroform extraction, the DNA was digested with restriction enzymes and ligated with Escherichia coli plasmid pHP34 or the Streptococcus-E. coli shuttle vector pSA3. TransfQrmation of E. coli HB101 with the recombinant molecules allowed selection of E. coli clones containing bacteriophage T12 genes. Immunological assays with specific antibody revealed the presence of type A streptococcal exotoxin in sonicates of E. coli transformants. Subcloning experiments localized the speA gene to a 1.7-kilobase segment of the bacteriophage T12 genome flanked by Sal and Hindlll sites. Introduction of the pSA3 vector containing the speA gene into Streptococcus sanguis (Challis) resulted in transformants that secreted the type A exotoxin. Immunological analysis showed that the type A streptococcal exotoxin produced by E.' coli and S. sanguis transformants, was identical to the type A exotoxin produced by S. pyogenes T253(T12). Southern blot hybridizations with the cloned fragment confirmed its presence in the bacteriophage T12 genome and its absence in the T253 nonlysogen. Therefore, the gene for type A streptococcal exotoxin is located in the bacteriophage genome, and conversion of S. pyogenes T253 to toxigenicity occurs in a manner similar to the conversion of Corynebacterium diphtheriae to toxigenicity by bacteriophage beta.
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Type A streptococcal exotoxin is a biologically active product secreted by bacteriophage-infected group A streptococci. This exotoxin, often referred to as Dick toxin (1), streptococcal pyrogenic exotoxin (45) , scarlet fever toxin (1), and erythrogenic toxin (44) , is one of three immunologically distinct streptococcal exotoxins, referred to as types A, B, and C.
The streptococcal exotoxins are responsible for a wide range of biological effects, including pyrogenicity (7, 27, 45) , erythematous skin reactions (10, 11, 19) , which may be due to enhancement of delayed hypersensitivity (39) , enhanced susceptibility to endotoxin shock (27, 40, 41, 44) , alteration of the blood-brain barrier (40) , cardiotoxicity (25, 41, 45) , Tcell mitogenicity (2, 21, 22, 28, 34, 37) , depression of clearance function of the reticuloendothelial system (8, 15) , and alteration of antibody response to sheep erythrocytes (9, 14, 16, 17) .
The possibility of bacteriophage involvement in type A streptococcal exotoxin production was introduced in 1927 when Frobisher and Brown reported that a filterable agent from streptococci associated with scarlet fever could induce exotoxin production when introduced into streptococci not previously associated with scarlet fever (12) . Bingel (6) later confirmed these results, and in 1964, Zabriskie (46) reported that infection of nontoxigenic Streptococcus pvogenes T253 with bacteriophage T12 resulted in the formation of a lysogen which secreted type A streptococcal exotoxin (erythrogenic toxin).
The molecular mechanism to account for this phagemediated toxigenic conversion has not been illustrated over the years, although Nida and Ferretti (35) and Johnson et al. (25) demonstrated that toxigenic conversion was not limited to the host T253-phage T12 system and that the phage used for lysogenic conversion determines the type of toxin produced by the lysogen.
Possible interactions between phage T12 and host S. pyogenes T253 that lead to type A exotoxin production have been suggested and include: (i) the bacteriophage contains the gene for type A exotoxin and a structural component of the phage such as the protein capsid is the toxin; (ii) the bacteriophage contains the gene, and a nonstructural gene product is actively synthesized during lysogeny; (iii) the bacterial chromosome contains the gene for type A exotoxin, and integration of the phage DNA into the host chromosome splits a gene coding for a nontoxic product, resulting in a toxic molecule which is the type A exotoxin; (iv) the bacterial chromosome-specified type A exotoxin is activated or derepressed by a phage product; and (v) a transposon contains the gene for type A exotoxin.
The first possibility was previously excluded owing to lack of immunological reactivity between the bacteriophage components and antibody to type A exotoxin and also lack of similarity between phage proteins and toxin proteins when compared by polyacrylamide gels (33) . Similarly, the third possibility was dismissed when it was determined that integration of the phage genome into the host chromosome was not essential for expression of the toxin gene (33) .
In (24) . MATERIALS AND METHODS Bacteria, bacteriophages, and plasmid vector. S. pyogenes T253(T12) (46) (23 Houston (20) and Dieter Gerlach (13) .
Media. The medium used for bacteriophage propagation was a supplemented proteose peptone broth, designated P broth (35) . Streptococcal strains were grown and maintained on a standard Todd-Hewitt medium (35) supplemented with 5% horse serum and 1.8 mM CaCI2. E. coli HB101 was grown in LB broth (30) . When necessary, ampicillin and tetracycline were added to the LB broth to a final concentration of 50 and 12.5 ,ug/ml, respectively. E. coli transformants were grown in LB broth containing 50 pg of ampicillin per ml and S. sanguis transformants were grown in BHI (brain heart infusion) broth containing 10 pg of erythromycin per ml when testing for type A streptococcal exotoxin. The medium used for exotoxin production by S. pyogenes NY-5 type 10 was BHI medium supplemented with 0.05% (wt/vol) glucose.
Enzymes. Restriction enzymes were purchased from Bethesda Research Labotatories, Gaithersburg, Md., and Boehringer-Mannheim, Federal Republic of Germany. Restriction enzyme digests were carried out according to the manufacturer's specifications. T4 DNA ligase was purchased from Amersham (Takara Shuzo, Japan).
Gel electrophoresis. Agarose gel electrophoresis was conducted through 1% agarose (type II, medium EEO) gels prepared in a Tris-acetate buffer composed of 0.04 M Trisacetate and 0.002 M EDTA and adjusted to pH 8.0 (32) . The gels were stained with ethidium bromide (0.5 ,ug/ml), and the DNA bands were visualized by UV light. Lambda DNA digested with HindIlI served as molecular weight standards.
Preparation of plasmid DNA. Large scale isolation of plasmid from E. coli was performed according to the cleared lysate method described by Behnke and Ferretti (4) , with minor modifications. Briefly, 100 ml of cells were grown overnight, washed, and suspended in 10 ml of a 15% sucrose solution (50 rnM EDTA, 50 mM Tris, 15% sucrose [pH 8.5]) and treated with 3 ml of lysozyme at 6 mg/ml in sucrose solution. After incubation at room temperature for 30 min, the cells were lysed with 0.75 ml of 20% sodium dodecyl sulfate, and 3.5 ml of 5 M NaCl was added to precipitate the protein and chromosomal DNA. The plasmid DNA was purified with two cycles of dye-buoyant density gradient centrifugation, dialyzed extensively against 10 mM Tris-1 mM EDTA, and stored at 4°C.
Streptococcal chromosomal DNA was isolated by the method of Behnke and Ferretti (4). Miniplasmid isolations from transformants were performed by the method of Holmes and Quigley (18) .
Preparation of bacteriophage T12 DNA. S. pyogenes T253c(T12) was inoculated into 10 ml of P broth and incubated overnight at 30°C. The culture was diluted 1:100 in 1 liter of prewarmed P broth and incubated for 1.5 h at 37°C. Phage T12 was induced by the addition of mitomycin C to a final concentration of 0.2 p.g/ml and incubation at 37°C for 3 h.
After the induction period, the remaining bacteria and cellular debris was pelleted by centrifugation, and the supernatant was filtered through a membrane filter (0.45 pLm pore size; Millipore Corp., Bedford, Mass.) to ensure removal of contaminating bacteria. Phage T12 was pelleted by ultracentrifugation at 200,000 x g for 1 h. The pellet was suspended in 10 mM Tris-1 mM EDTA (pH 7.5), and the protein coat was removed by three extractions with an equal volume of phenol-chloroform. The DNA solution was washed once with chloroform and precipitated overnight at -20°C with 2 volumes of 95% ethanol. The DNA was pelleted and suspended in 10 mM Tris-1 mM EDTA, pH 7.5.
Construction of pHP34-phage T12 chimeric plasmids. Bacteriophage T12 DNA and plasmid pHP34 were digested with EcoRI and Sall, mixed, and ligated overnight with 1 U of T4 DNA ligase at 14°C as described by Behnke and Gilmore (5 Sonification of transformants and testing for type A exotoxin production. E. coli transformants were inoculated into 100 ml of LB broth containing 50 p.g of ampicillin per ml and incubated overnight at 37°C. The cells were pelleted by centrifugation, and the supernatant was concentrated by precipitation with 4 volumes of cold 95% ethanol for 48 h at 4°C (25) . After precipitation, the ethanol was decanted, and the precipitate was suspended into 0.5 ml of 10 mM Tris (pH 8.0). To test for cytoplasmic or periplasmic toxin, the E. coli cell pellet was suspended in 0.5 ml of 10 mM Tris, pH 8.0, and incubated with 0.25 mg of lysozyme per ml for 30 min at 37°C. Cells were disrupted with three 15-s bursts with a sonic machine (Sonicator model W-275R, Heat Systems-Ultrasonics, Inc.). The resulting cell lysates were centrifuged at 6,000
x g for 15 min at 4°C to pellet the cellular debris, and the supernatant was tested for type A exotoxin. The Ouchterlony double-diffusion method (36) S. sanguis transformants were inoculated into 100 ml of BHI broth containing 10 p.g of erythromycin per ml and incubated overnight at 37°C. The cell-free culture medium was concentrated by ethanol precipitation, and the resulting precipitate was suspended in 0.5 ml of 10 mM Tris (pH 8.0). The concentrated culture medium was tested for type A streptococcal exotoxin by the Ouchterlony double-diffusion method described above.
Biological activity of the cloned type A streptococcal exotoxin. The cloned type A streptococcal exotoxin was tested for biological activity by the erythematous skin test as described by Houston and Ferretti (20 negative controls, respectively. The rabbit skins were observed at 24 and 48 h for the erythematous skin response.
Southern hybridization. Southern transfer, nick translation, and in situ hybridization of plasmid containing the 1.7-kb phage T12 fragment to the nitrocellulose filters was performed by the method of Southern (42) as described by Maniatis et al. (32) . Briefly, phage T12 DNA and T253c nonlysogen DNA were digested with EcoRI and Sall, and the DNA fragments were separated by agarose gel electrophoresis. The separated fragments were transferred to nitrocellulose paper, and the transferred fragments were hybridized with a [32P]ATP-labeled p1179 probe (containing the 1.7-kb fragment). Autoradiography of the nitrocellulose paper revealed hybridization patterns.
Construction of lysogens. The S. pyogenes lysogen T253c(T12) was constructed by infecting the bacterial strain T253c with the bacteriophage T12 [obtained from T253(T12)] by the methods of Nida and Ferretti (35) .
RESULTS
Cloning of the type A streptococcal exotoxin gene from bacteriophage T12 into pHP34. The lysogenic strain of S. pyogenes T253(T12) in our collection was the same as that described by Zabriskie (46) , and when induced with mitomycin C, it yielded phage DNA that was different in size and restriction enzyme digestion patterns than that reported by Johnson and Schlievert (23) . However, construction of the T253c(T12) lysogen with phage T12 obtained from the original lysogenic strain gave phage upon induction that appeared to be identical to that described by Johnson and Schlievert (23 taining the chimeric plasmids were analyzed for the presence of secreted or nonsecreted type A streptococcal exotoxin with specific antiserum by the Ouchterlony double-diffusion method. Cell extracts of the transformant clones were obtained by sonication and were applied to wells opposite a well containing specific type A streptococcal exotoxin. One of the transformants (designated pA2) which contained a 4.75-kb ( Fig. 1 ) fragment of the bacteriophage T12, synthesized the type A streptococcal exotoxin as evidenced by a line of identity with the type A exotoxin secreted by S. pyogenes NY-5 type 10 ( Fig. 2) . Culture supernatants obtained from this E. coli transformant (designated pA2) were also tested with specific antibody; however, we did not find any evidence of exotoxin presence in the extracellular fluid.
The chimeric plasmid pA2 was digested with various restriction enzymes to construct a physical map of the 4.75-kb phage T12 DNA insert, as shown in Fig. 3 .
Subcloning of the type A streptococcal exotoxin gene. Digestion of pA2 with Sall and HindlIl, produced a 1.7-kb fragment that could be potentially subcloned into pBR322. Digestion of pA2 with Sall and HindIll and subsequent ligation to Sall-and HindlIl-digested pBR322 resulted in plasmids that contained the 1.7-kb insert (designated p1179). Cell-free extracts of these transformants were analyzed by the Ouchterlony double-diffusion method with specific type A exotoxin antibody, and it was determined that the 1.7-kb Hindlll and Sall fragment produced type A exotoxin that gave a line of identity with type A exotoxin produced by the pA2 plasmid (containing the 4.75-kb phage T12 fragment) and that produced extracellularly by S. pyogenes NY-5 type 10. The plasmid p1179 was subsequently digested with Sall and EcoRI, and the 1. (Fig. 4) Although these experiments have demonstrated that the gene for type A streptococcal exotoxin is located on the bacteriophage T12 genome, they do not eliminate the possibility that the type A streptococcal exotoxin gene is located on a transposon, and transposition from the chromosome to the phage genome (or vice versa) occurs. Southern hybridization of the cloned toxin gene to numerous strains of streptococci associated with scarlet fever and phage induced from these clinical strains should allow examination of this possibility. The discovery of streptococcal strains associated with scarlet fever, in which the chromosome contains the speA gene and whose temperate phage do not encode the speA gene, would support this hypothesis. Nucleotide sequence data of the 1.7-kb fragment may reveal the presence of insertion sequences that may allow transposition. Finally, numerous phage-host systems will need to be examined to determine whether the phage T12-host T25, system is ubiquitous among strains of S. pvogen,es associated with scarlet fever.
In conclusion, information obtained from this study indicates that phage T12 conversion of S. pyogenes T253 is analogous to the phage conversion system of C. diplitlier-iCti by,-prophage. Other phage-host systems will have to be examined to determine whether the same interaction occurs among other clinical group A streptococcal lysogens.
